25.34
Roundhill Glp 1 Weight Loss Etf 주식(OZEM)의 최신 뉴스
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire Professional Buyer
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Roundhill Investments Surpasses $4 Billion AUM Milestone – Company Announcement - Financial Times
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Eli Lilly Lowers Q4 Sales Outlook: Best ETFs to Consider Now - espeaks.co.uk
ROUNDHILL -- A "Roundhill Roundup" -- all Roundhill Investments products since inception - substack.com
Jane Street Group LLC Has $1.16 Million Stock Position in Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) - Defense World
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares - Benzinga
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tap the Weight-Loss Drug Market With These ETFs - Yahoo Finance
Roundhill Investments Surpasses $2 Billion AUM Milestone – Company Announcement - Financial Times
Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch - CNBC
Disruptive Theme of the Week: Playing Defense - ETFdb.com
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
Dr. Sanjay Gupta On Call: What are your questions about weight loss drugs? - Yahoo Lifestyle UK
Weight loss drug may cut heart failure risk, company says - Yahoo News Australia
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials - Yahoo Singapore News
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea - Yahoo Canada Shine On
Weight-loss ETFs demand some heavy thinking - Financial Times
Diabetes drug recommended to treat obesity on the NHS - Yahoo News UK
ETFs to Profit from the Weight Loss Drug Boom - Yahoo Finance
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - Markets Insider
OZEM, Weight Loss Drug ETFs: Should You Invest? - etf.com
Did South Park mark the top for weight-loss stocks? - Sherwood News
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - Benzinga
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
ETFs Targeting Weight-Loss Market Gain Traction - Finimize
Roundhill Investment launches GLP-1 & Weight Loss ETF (NASDAQ:OZEM) - Seeking Alpha
Fund Files: Eaton Vance, Voya PMs to depart; Roundhill launches active weight loss ETF - Citywire Professional Buyer
EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga - Markets Insider
Thematic ETF Winners of the Q1 2024 Earnings Season - ETF Trends
Tori Spelling reveals she tried Ozempic, Mounjaro after birth of fifth child - Yahoo Lifestyle Australia
Roundhill names new CEO - Citywire Professional Buyer
Weight Loss Drugs Zepbound and Mounjaro Are in Shortage Due to 'Demand Increase,' FDA Says - Yahoo News Canada
Two fresh ways to play the weight loss and megacap tech hype - CNBC
Experts hesitate on weight loss ETFs amid the obesity drug boom - CNBC
Roundhill Investments - etf.com
자본화:
|
볼륨(24시간):